JP2023546277A5 - - Google Patents
Info
- Publication number
- JP2023546277A5 JP2023546277A5 JP2023547735A JP2023547735A JP2023546277A5 JP 2023546277 A5 JP2023546277 A5 JP 2023546277A5 JP 2023547735 A JP2023547735 A JP 2023547735A JP 2023547735 A JP2023547735 A JP 2023547735A JP 2023546277 A5 JP2023546277 A5 JP 2023546277A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- fragment
- cells
- cancer
- immunoactive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2020120869 | 2020-10-14 | ||
| CNPCT/CN2020/120869 | 2020-10-14 | ||
| CN2020122188 | 2020-10-20 | ||
| CNPCT/CN2020/122188 | 2020-10-20 | ||
| PCT/CN2021/123892 WO2022078465A1 (en) | 2020-10-14 | 2021-10-14 | Novel anti-cd47 antibodies and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023546277A JP2023546277A (ja) | 2023-11-01 |
| JP2023546277A5 true JP2023546277A5 (https=) | 2024-12-11 |
Family
ID=81207683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023547735A Withdrawn JP2023546277A (ja) | 2020-10-14 | 2021-10-14 | 新規の抗ｃｄ４７抗体及びその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230399400A1 (https=) |
| EP (1) | EP4229088A1 (https=) |
| JP (1) | JP2023546277A (https=) |
| KR (1) | KR20230114745A (https=) |
| CN (1) | CN116348601A (https=) |
| AU (1) | AU2021360633A1 (https=) |
| CA (1) | CA3198895A1 (https=) |
| CO (1) | CO2023005611A2 (https=) |
| IL (1) | IL302112A (https=) |
| MX (1) | MX2023004223A (https=) |
| TW (1) | TW202229351A (https=) |
| WO (1) | WO2022078465A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017332960B2 (en) | 2016-10-20 | 2019-09-12 | I-Mab Biopharma Us Limited | Novel CD47 monoclonal antibodies and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017332960B2 (en) * | 2016-10-20 | 2019-09-12 | I-Mab Biopharma Us Limited | Novel CD47 monoclonal antibodies and uses thereof |
| WO2019091473A1 (en) * | 2017-11-10 | 2019-05-16 | I-Mab Biopharma Co., Ltd. | Fusion proteins containing cd47 antibodies and cytokines |
| WO2020036977A1 (en) * | 2018-08-13 | 2020-02-20 | Arch Oncology, Inc. | Therapeutic cd47 antibodies |
| AU2019370754A1 (en) * | 2018-10-31 | 2021-02-04 | I-Mab Biopharma Us Limited | Novel CD47 antibodies and methods of using same |
| CA3097443A1 (en) * | 2018-11-12 | 2020-05-22 | I-Mab Biopharma Us Limited | Fusion proteins containing cd47 antibodies and cytokines |
-
2021
- 2021-10-14 AU AU2021360633A patent/AU2021360633A1/en not_active Abandoned
- 2021-10-14 KR KR1020237016071A patent/KR20230114745A/ko not_active Withdrawn
- 2021-10-14 EP EP21879507.8A patent/EP4229088A1/en not_active Withdrawn
- 2021-10-14 US US18/249,054 patent/US20230399400A1/en active Pending
- 2021-10-14 MX MX2023004223A patent/MX2023004223A/es unknown
- 2021-10-14 JP JP2023547735A patent/JP2023546277A/ja not_active Withdrawn
- 2021-10-14 TW TW110138242A patent/TW202229351A/zh unknown
- 2021-10-14 WO PCT/CN2021/123892 patent/WO2022078465A1/en not_active Ceased
- 2021-10-14 CA CA3198895A patent/CA3198895A1/en active Pending
- 2021-10-14 IL IL302112A patent/IL302112A/en unknown
- 2021-10-14 CN CN202180068919.2A patent/CN116348601A/zh active Pending
-
2023
- 2023-05-02 CO CONC2023/0005611A patent/CO2023005611A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102068600B1 (ko) | Pdl-1 항체, 그 약학적 조성물 및 그 용도 | |
| JP2020520370A5 (https=) | ||
| JP2021510736A5 (https=) | ||
| JP2022533538A5 (https=) | ||
| JP2013520984A (ja) | 抗ｈｅｒ２抗体および組成物 | |
| JP2023518153A5 (https=) | ||
| JP2024520188A5 (https=) | ||
| JPWO2014065402A1 (ja) | 抗ヒトｃｄ４０モノクローナル抗体及びその利用 | |
| JP2024016024A5 (https=) | ||
| JP2024515536A5 (https=) | ||
| EP3929213A1 (en) | Anti-pd-l1 antibody and use thereof | |
| CN112351794A (zh) | 用于尿路上皮癌的免疫治疗方法 | |
| JP2023543826A (ja) | 抗ｃｄ３抗体およびその使用 | |
| KR20220042258A (ko) | 항 tigit 항체 및 그의 응용 | |
| JP2023547506A5 (https=) | ||
| JP2023549316A5 (https=) | ||
| JP2022517216A5 (https=) | ||
| JP2023517794A5 (https=) | ||
| CN114450025A (zh) | 使用包含多重酪氨酸激酶抑制剂和免疫检查点抑制剂的组合治疗癌症 | |
| JP2024527576A5 (https=) | ||
| JP2023546277A5 (https=) | ||
| JP2022548881A5 (https=) | ||
| JP2026506070A (ja) | 抗ｃｎｔｎ４抗体及びその使用 | |
| JP2022521773A5 (https=) | ||
| IL321677A (en) | Anti-PDL1 antibodies, multispecific antibodies, and methods of use |